Rosalind Tremaine

Sydney-based medical science writer with a PhD in molecular oncology from the Garvan Institute of Medical Research. Worked for eight years as a bench scientist on KRAS signalling before moving to full-time science journalism. Writes a regular column for a major Australian health publication and contributes to The Conversation on precision oncology topics.

2 articles published